Onconova Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Its lead compound, Rigosertib, is being evaluated in several ongoing clinical trials for the treatment of various types of cancer. The company’s innovative approach and strong pipeline make it an exciting player in the oncology space.
